HKEX: 1177 - Sino Biopharmaceutical Limited

Yield per half year: +4.32%
Dividend yield: +2.83%
Sector: Healthcare

Share chart Sino Biopharmaceutical Limited


About Sino Biopharmaceutical Limited

Sino Biopharmaceutical Limited, инвестиционная холдинговая компания, работает как научно-исследовательский фармацевтический конгломерат в Китайской Народной Республике. Он работает в трех сегментах: модернизированные китайские лекарства и химические лекарства, инвестиции и другие.

more details
Компания предлагает лекарства от онкологии, включающие таблетки Qingkeshu, капсулы Focus V, инъекции Annike и капсулы Anyue; лекарства от болезней печени, включая инъекции Tianqing ganmei и диспергируемые таблетки Runzhong; и лекарственные средства для респираторной системы, такие как суспензия Tianqingsuchang для ингаляций и Tianyun для инъекций. Он также предоставляет лекарства для хирургии / обезболивания, включая катаплазмы Дебайан и мягкие капсулы Гайсанчунь; и сердечно-сосудистые препараты, в том числе таблетки Yilunping и Kaina. Кроме того, компания занимается долгосрочными инвестициями; и здравоохранение и больничный бизнес. Компания была зарегистрирована в 2000 году и имеет штаб-квартиру в Ван Чай, Гонконг.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2000-09-29
ISIN KYG8167W1380
Industry Pharmaceuticals
Sector Health Care
Валюта hkd
Валюта отчета cny
Див.доход ао 1.55
Дивиденд ао 0.06
Сайт https://www.sinobiopharm.com
Цена ао 2.9
Change price per day: -0.3436% (2.91)
Change price per week: +1.75% (2.85)
Change price per month: -10.22% (3.23)
Change price per 3 month: -21.2% (3.68)
Change price per half year: +4.32% (2.78)
Change price per year: +1.4% (2.86)
Change price per 3 year: -53.3% (6.21)
Change price per 5 year: -80.86% (15.15)
Change price per 10 year: 0% (2.9)
Change price per year to date: -9.66% (3.21)
All parameters

Underestimation

Title Value Grade
P/S 2.08 7
P/BV 1.43 9
P/E 23.35 6
EV/EBITDA 11.92 7
Total: 8.13

Efficiency

Title Value Grade
ROA, % 3.65 1
ROE, % 7.74 2
Total: 2.33

Dividends

Title Value Grade
Div yield, % 2.83 7.08
DSI 0.7857 7.86
Total: 5.33

Debt

Title Value Grade
Debt/EBITDA 1.94 7
Total: 6.8

Growth impulse

Title Value Grade
Yield Revenue, % 8.11 2
Yield Ebitda, % 4.59 1
Yield EPS, % -26.15 0
Total: 1.4
More

ETF Share, % Profitability for 1 year, % Dividends, %
KraneShares MSCI All China Health Care Index ETF 2.81586 15.16 2.31691
Loncar China BioPharma ETF 2.15 18434.25
Vident International Equity Strategy ETF 0.50551 6.83 5.52154
WisdomTree China ex-State-Owned Enterprises Fund 0.37923 13.84 2.29363
VictoryShares International Value Momentum ETF 0.37635 3.72 4.72459
KraneShares MSCI All China Index ETF 0.25852 11.71 3.90687
Franklin FTSE China ETF 0.20843 14.5 3.35323
SPDR S&P China ETF 0.18912 17.02 3.40103
Avantis Responsible Emerging Markets Equity ETF 0.16928 17.6 3.1719
Goldman Sachs ActiveBeta Emerging Markets Equity ETF 0.13293 9.13 3.47133
Nuveen ESG Emerging Markets Equity ETF 0.10825 11.62 2.89278
Avantis Emerging Markets Equity ETF 0.10489 8.77 3.60513
Dimensional Emerging Markets Core Equity 2 ETF 0.10382 15.96 3.34087
Invesco FTSE RAFI Emerging Markets ETF 0.10324 10.8 4.9487
Xtrackers MSCI Emerging Markets ESG Leaders Equity ETF 0.10232 17.59 2.86877
SPDR MSCI Emerging Markets Fossil Fuel Free ETF 0.09955 14.02 2.84808
SPDR Portfolio Emerging Markets ETF 0.06464 11.59 3.1879
Schwab Fundamental Emerging Markets Equity ETF 0.06032 10.75 5.10539
Avantis Emerging Markets Value ETF 0.0589 14.12 4.22231
Franklin FTSE Asia ex Japan ETF 0.05429 14.43 2.66768
Xtrackers MSCI Emerging Markets Hedged Equity ETF 0.05411 15.84 3.04307
First Trust Emerging Markets Small Cap AlphaDEX Fund 0.05316 1061.14 2.70393
WisdomTree Emerging Markets Efficient Core Fund 0.04881 17.03 3.08497
SPDR MSCI Emerging Markets StrategicFactors ETF 0.03714 8.65 3.55491
Schwab Fundamental International Small Co. Index ETF 0.03587 8.31 3.46652
IQ Candriam International Equity ETF 0.03506 10.11 3.0914
Dimensional World ex U.S. Core Equity 2 ETF 0.03443 13.06 3.62488
SPDR MSCI ACWI ex-US ETF 0.03179 7.85 3.3217
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.0278 12.46 3.59676
John Hancock Multifactor Emerging Markets ETF 0.02654 4.68 3.42078
Goldman Sachs MarketBeta International Equity ETF 0.02312 5.33 3.36845
BNY Mellon International Equity ETF 0.02003 11.1 3.33394
Vanguard ESG International Stock ETF 0.02 6.39 3.07501
Xtrackers MSCI All World ex US Hedged Equity ETF 0.01441 18.18 3.26685
SPDR MSCI ACWI Climate Paris Aligned ETF 0.01063 25.32 1.86415
iShares MSCI ACWI ETF 0.00842 -19.68 2.10908
SPDR Portfolio MSCI Global Stock Market ETF 0.00414 17.99 2.19607



Head Job title Payment Year of birth
Ms. Y. Y. Tse Executive Chairwoman of the Board 42.97M 1992 (33 years)
Mr. Eric S. Y. Tse CEO & Executive Director 25.02M 1996 (29 years)
Mr. Ping Tse Founder & Senior Executive Vice Chairman 45.43M 1952 (73 years)
Ms. Cheung Ling Cheng Executive Vice Chairwoman of the Board 38.12M 1964 (61 year)
Mr. Zhoushan Tian Executive Director 2.03M 1964 (61 year)
Mr. Hsin Tse Senior VP & Executive Director 6.53M 1970 (55 years)
Ms. Chun Ling Li Chief Financial Officer N/A 1972 (53 years)
Mr. Song Jin Vice President of Public Affairs, Medicines Policies & ESG 1976 (49 years)
Mr. Sean Chen Chief Strategy Officer 1978 (47 years)
Ms. Chau Ling Yu Assistant VP & Financial Controller 1969 (56 years)

Address: Hong Kong, Wan Chai, Unit 09 Office Tower - open in Google maps, open in Yandex maps
Website: https://www.sinobiopharm.com